Veraxa Biotech Holding AG's total liabilities is $290M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2026), VRXA shows a total liabilities of $290M. That compares with $12M in the prior-year period — up 2263.6% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, VRXA's total liabilities is now $290M (was $12M) — a 2263.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Veraxa Biotech Holding AG is outperforming or lagging.
Tracking VRXA's total liabilities over time shows whether Veraxa Biotech Holding AG is scaling, shrinking, or reshaping that part of the business. The current reading is $290M That compares with $12M in the prior-year period — up 2263.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total liabilities page, Stockcircle has Veraxa Biotech Holding AG's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $290M) with ownership activity and broader fundamentals.